GXMC
HZNP

Global X Management Company’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Global X Management Company’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-77,140
Closed -$978K – 1099
2017
Q3 		$978K Sell
77,140
-9,842
-11% -$125K 0.03% 364
2017
Q2 		$1.03M Buy
86,982
+30,908
+55% +$384K 0.03% 336
2017
Q1 		$829K Buy
56,074
+5,268
+10% +$85.3K 0.03% 359
2016
Q4 		$822K Sell
50,806
-11,668
-19% -$212K 0.04% 307
2016
Q3 		$1.13M Sell
62,474
-45,242
-42% -$884K 0.05% 269
2016
Q2 		$1.77M Sell
107,716
-20,358
-16% -$329K 0.09% 223
2016
Q1 		$2.12M Sell
128,074
-74,560
-37% -$1.3M 0.13% 224
2015
Q4 		$4.39M Buy
202,634
+48,900
+32% +$952K 0.3% 130
2015
Q3 		$3.05M Sell
153,734
-50,431
-25% -$1.59M 0.23% 174
2015
Q2 		$7.09M Buy
204,165
+203,035
+17,968% +$6.2M 0.39% 92
2015
Q1 		$29K Sell
1,130
-539
-32% -$9.88K ﹤0.01% 399
2014
Q4 		$22K Sell
1,669
-558
-25% -$6.99K ﹤0.01% 465
2014
Q3 		$27K Buy
2,227
+623
+39% +$7.24K ﹤0.01% 400
2014
Q2 		$25K Buy
+1,604
New +$22.9K ﹤0.01% 428

Other funds holding HZNP

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Global X Management Company's HZNP Position: Q4 2017 in Review

Global X Management Company sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2017, closing a stake of 77,140 shares — an estimated $978K sold.

Global X Management Company first reported a position in HZNP in Q2 2014 and held it in 14 quarters. The position peaked at $7.09M in Q2 2015. 183 funds tracked by Wall St. Rank hold HZNP as of Q4 2017.

  • Global X Management Company reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Global X Management Company sold 77,140 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2017, an estimated $978K.
  • Global X Management Company first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2014 and held it in 14 quarters.
  • Global X Management Company's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7.09M in Q2 2015.
  • 183 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2017.

Based on Global X Management Company's 13F filing for Q4 2017, filed 8 Feb 2018.